Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the “Real World”

Michał Mazurek; Professor Gregory Lip

doi:10.1053/j.gastro.2017.02.027

Related publications

Article2023

Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia

Nour R. Al‐Hussainy, Kristian Kragholm, Søren Lundbye‐Christensen, Christian Torp‐Pedersen, Manan Pareek, Susette Krohn Therkelsen, Professor Gregory Lip, Sam Riahi

Article2021

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants

Anne Gulbech Ording, Mette Søgaard, Flemming Skjøth, Erik Lerkevang Grove, Professor Gregory Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen

Article2021

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding

Professor Gregory Lip, Allison Keshishian, Yan Zhang, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Hüseyin Yüce, Steven Deitelzweig

Article2021

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding

Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2020

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

Yi‐Hsin Chan, Lung‐Sheng Wu, Lai‐Chu See, Jia‐Rou Liu, Shang‐Hung Chang, Tze‐Fan Chao, Yung‐Hsin Yeh, Chi‐Tai Kuo, Hsin‐Fu Lee, Professor Gregory Lip

Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the “Real World”

Discussion(0)

Related publications

Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism